Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Atossa Therapeutics, Inc. ATOS

Full chart Compare
Set alert

Price alert · ATOS

All alert types
2.33 USD +0.03 (+1.30%)

At closeNov 3, 2026, 4:17 PM EST

2.27 -0.06 -2.58%

After hours · Nov 3, 4:17 PM ET

2.27 Day range 2.35
1.70 52-week range 14.85
YTD
-73.67%
1 year
-81.94%

Financial health

Altman Z-Score

-11.81 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -2.2×
FY 2016: -0.7×FY 2017: -0.3×FY 2018: -0.2×FY 2019: -0.8×FY 2020: -0.5×FY 2021: -8.9×FY 2022: -2.5×FY 2023: -3.7×FY 2024: -4.7×FY 2025: -2.2×
FY 2016 5y median -3.7× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 1.9×
FY 2016: 1.3×FY 2017: 0.4×FY 2018: 0.5×FY 2019: 1.0×FY 2020: 0.4×FY 2021: 1.4×FY 2022: 0.6×FY 2023: 1.2×FY 2024: 1.7×FY 2025: 1.9×
FY 2016 5y median 1.4× FY 2025
P/FCF -2.6×
FY 2016: -0.8×FY 2017: -0.5×FY 2018: -0.5×FY 2019: -1.5×FY 2020: -0.9×FY 2021: -11.4×FY 2022: -3.2×FY 2023: -5.3×FY 2024: -5.6×FY 2025: -2.6×
FY 2016 5y median -5.3× FY 2025
EV/EBITDA -1.0×
FY 2016: -0.2×FY 2017: 0.5×FY 2018: 0.5×FY 2019: -0.0×FY 2020: 2.0×FY 2021: -2.5×FY 2022: 1.6×FY 2023: -0.7×FY 2024: -1.9×FY 2025: -1.0×
FY 2016 5y median -1.0× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -39.1%
FY 2016: -129.6%FY 2017: -216.8%FY 2018: -213.9%FY 2019: -68.5%FY 2020: -107.8%FY 2021: -8.8%FY 2022: -31.0%FY 2023: -18.9%FY 2024: -17.7%FY 2025: -39.1%
FY 2016 5y median -18.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -88.4%
FY 2016: -205.6%FY 2017: -117.1%FY 2018: -129.5%FY 2019: -131.0%FY 2020: -65.6%FY 2021: -14.9%FY 2022: -22.9%FY 2023: -33.1%FY 2024: -35.7%FY 2025: -88.4%
FY 2016 5y median -33.1% FY 2025
ROIC -94.4%
FY 2016: -234.1%FY 2017: -103.6%FY 2018: -129.5%FY 2019: -130.6%FY 2020: -53.7%FY 2021: -14.9%FY 2022: -23.5%FY 2023: -34.5%FY 2024: -38.6%FY 2025: -94.4%
FY 2016 5y median -34.5% FY 2025
ROA -73.0%
FY 2016: -153.7%FY 2017: -99.5%FY 2018: -97.3%FY 2019: -118.9%FY 2020: -41.6%FY 2021: -14.6%FY 2022: -21.8%FY 2023: -31.3%FY 2024: -33.4%FY 2025: -73.0%
FY 2016 5y median -31.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -100.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -34.5%
FY 2016: 43.2%FY 2017: 0.9%FY 2018: -59.1%FY 2019: -51.0%FY 2020: 15.4%FY 2021: -40.5%FY 2022: -34.9%FY 2023: -13.3%FY 2024: 12.0%FY 2025: -34.5%
FY 2016 FY 2025
EPS (diluted) -34.7%
FY 2016: 72.9%FY 2017: 57.7%FY 2018: 49.9%FY 2019: 63.1%FY 2020: 3.0%FY 2021: 90.9%FY 2022: -16.7%FY 2023: -14.3%FY 2024: 16.7%FY 2025: -34.7%
FY 2016 FY 2025
Free Cash Flow -41.5%
FY 2016: 61.8%FY 2017: -22.5%FY 2018: -37.6%FY 2019: -0.7%FY 2020: -26.7%FY 2021: -42.3%FY 2022: -26.1%FY 2023: -0.8%FY 2024: -0.4%FY 2025: -41.5%
FY 2016 FY 2025

Financial Health

Current Ratio 5.5×
FY 2016: 3.1×FY 2017: 6.4×FY 2018: 4.0×FY 2019: 10.8×FY 2020: 2.7×FY 2021: 45.2×FY 2022: 21.2×FY 2023: 17.6×FY 2024: 15.0×FY 2025: 5.5×
FY 2016 5y median 17.6× FY 2025
Quick Ratio 5.5×
FY 2016: 3.1×FY 2017: 6.4×FY 2018: 4.0×FY 2019: 10.8×FY 2020: 2.7×FY 2021: 45.2×FY 2022: 20.3×FY 2023: 17.3×FY 2024: 15.0×FY 2025: 5.5×
FY 2016 5y median 17.3× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 1.2×
FY 2016: 0.5×FY 2017: 0.9×FY 2018: 0.9×FY 2019: 0.7×FY 2020: 2.7×FY 2021: 6.6×FY 2022: 4.1×FY 2023: 2.9×FY 2024: 2.8×FY 2025: 1.2×
FY 2016 5y median 2.9× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: -37.3×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31